Michelangelo Fiorentino

A preliminary study investigating the detection of lymphovascular invasion in germ cell tumors of the testis with double staining for OCT4/CD34.

Ricci C, Franceschini T, Giunchi F, Borsato M, Mollica V, Massari F, Fiorentino M.

Pathol Res Pract. 2021 Sep 29. 227:153637. PMID: 34619577

HMB45/PRAME, a Novel Double Staining for the Diagnosis of Melanocytic Neoplasms: Technical Aspects, Results, and Comparison With Other Commercially Available Staining (PRAME and Melan A/PRAME).

Grillini M, Ricci C, Pino V, Pedrini S, Fiorentino M, Corti B.

Appl Immunohistochem Mol Morphol. 2021 Sep 10. PMID: 34508017

Platinum-based adjuvant chemotherapy for upper tract urothelial carcinoma: a change of paradigm? A meta-analysis of aggregate data.

Ricci AD, Rizzo A, Mollica V, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F.

Anticancer Drugs. 2021 Aug 11. PMID: 34387596

The Use of Augmented Reality to Guide the Intraoperative Frozen Section During Robot-assisted Radical Prostatectomy.

Bianchi L, Chessa F, Angiolini A, Cercenelli L, Lodi S, Bortolani B, Molinaroli E, Casablanca C, Droghetti M, Gaudiano C, Mottaran A, Porreca A, Golfieri R, Romagnoli D, Giunchi F, Fiorentino M, Piazza P, Puliatti S, Diciotti S, Marcelli E, Mottrie A, Schiavina R.

Eur Urol. 2021 Oct. 80(4):480-488. PMID: 34332759

[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial.

Zanoni L, Bianchi L, Nanni C, Pultrone C, Giunchi F, Bossert I, Matti A, Schiavina R, Fiorentino M, Romagnoli D, Fonti C, Lodi F, D'Errico A, Brunocilla E, Porreca A, Fanti S.

Eur J Nucl Med Mol Imaging. 2021 Jul 02. PMID: 34213609

The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What's the Story Morning Glory?

Marchetti A, Rosellini M, Mollica V, Rizzo A, Tassinari E, Nuvola G, Cimadamore A, Santoni M, Fiorentino M, Montironi R, Massari F.

Int J Mol Sci. 2021 Jun 09. 22(12). PMID: 34207825

Giant (pseudo) vascular spiradenoma: a case report of an extremely rare entity with the immunohistological demonstration of the coexistence of vascular and pseudo-vascular components.

Ricci C, Ambrosi F, Dika E, Lambertini M, Chillotti S, Fiorentino M, Corti B.

Ital J Dermatol Venerol. 2021 Apr 23. PMID: 33890732

Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials.

Rizzo A, Mollica V, Rosellini M, Marchetti A, Ricci AD, Fiorentino M, Battelli N, Santoni M, Massari F.

Pathol Res Pract. 2021 Jun. 222:153440. PMID: 33857854

The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis.

Zanoni L, Mei R, Bianchi L, Giunchi F, Maltoni L, Pultrone CV, Nanni C, Bossert I, Matti A, Schiavina R, Fiorentino M, Fonti C, Lodi F, D'Errico A, Brunocilla E, Fanti S.

Cancers (Basel). 2021 Mar 29. 13(7). PMID: 33805543

Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance.

Borghesi M, Bianchi L, Barbaresi U, Vagnoni V, Corcioni B, Gaudiano C, Fiorentino M, Giunchi F, Chessa F, Garofalo M, Bertaccini A, Angelini S, Ercolino A, Casablanca C, Droghetti M, Golfieri R, Schiavina R.

Minerva Urol Nephrol. 2021 Jun. 73(3):357-366. PMID: 33769008